LG Life Sciences’ single dose treatment of osteoarthritis Synovan Inj obtained the European CE certification

Published: 2014-08-22 09:47:49

Updated: 2014-08-22 09:47:49

On August 20, LG Life Sciences announced that the first Korean developed single dose treatment of osteoarthritis drug Synovan Inj obtained the European CE certification.

LG Life Sciences received this certificatio based on the clinical results and a lot of safety evidence, and it became possible to export to more than 30 countries in Europe.

According to LG Life Sciences, Synovian Inj is a ne...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.